DAIICHI SANKYO COMPANY,LIMITED 4568Short Interest
No institution currently reports a short position of 0.5% or more in DAIICHI SANKYO COMPANY,LIMITED (4568). The last disclosure was on 2026-10-13 (J.P. MORGAN SECURITIES PLC, 0.26%).
Estimated short interest
0.00%
±0.00%
Estimated position (shares)
0
As of 2026-11-18
Holders (0.5% or more)
0 firms
15 reports
Estimated short interest is the sum of positions of 0.5% or more reported within the past year. It also excludes 2 institutions that fell below 0.5%. How estimates are calculated
Disclosure History Summary
| First disclosure | 2026-04-07 |
|---|---|
| Latest disclosure | 2026-10-13 (J.P. MORGAN SECURITIES PLC, 0.26%) |
| Reporting institutions | 2 firms (15 reports) |
| Peak estimated short interest | 2.27% (2026-09-16, 2 holders) |
Short Interest Trend Last 5 years, by institution, % of shares outstanding
Estimated short interest stacked by institution, counting only positions of 0.5% or more reported within the past year. The 2 largest current holders are colored and the rest are grouped as "Others". Hover over (or tap) a bar to see the breakdown.
- J.P. MORGAN SECURITIES PLC
- BNP Paribas Financial Markets SNC
0.00%
Estimated short interest, 2026-11-18
Current Positions by Short Seller Latest report of each holder
| Last report | Short seller | Position (shares) | Ratio | Change | Status |
|---|---|---|---|---|---|
| 2026-10-13 | J.P. MORGAN SECURITIES PLC | Position 4,858,089 shares | Ratio 0.26% | ▼0.40% | Below 0.5% |
| 2026-09-30 | BNP Paribas Financial Markets SNC | Position 4,438,622 shares | Ratio 0.23% | ▼0.36% | Below 0.5% |
Disclosure History 15 in total
| Trade date | Short seller | Position (shares) | Ratio | Change | Note |
|---|---|---|---|---|---|
| 2026-10-13 | J.P. MORGAN SECURITIES PLC | Position 4,858,089 shares | Ratio 0.26% | ▼0.40% | Below 0.5% |
| 2026-10-06 | J.P. MORGAN SECURITIES PLC | Position 12,456,084 shares | Ratio 0.66% | ▼0.90% | — |
| 2026-10-05 | J.P. MORGAN SECURITIES PLC | Position 29,077,484 shares | Ratio 1.56% | ▲0.14% | — |
| 2026-09-30 | BNP Paribas Financial Markets SNC | Position 4,438,622 shares | Ratio 0.23% | ▼0.36% | Below 0.5% |
| 2026-09-25 | BNP Paribas Financial Markets SNC | Position 11,096,405 shares | Ratio 0.59% | ▼0.07% | — |
| 2026-09-17 | BNP Paribas Financial Markets SNC | Position 12,360,724 shares | Ratio 0.66% | ▼0.19% | — |
| 2026-09-16 | J.P. MORGAN SECURITIES PLC | Position 26,568,833 shares | Ratio 1.42% | ▲0.21% | — |
| 2026-09-16 | BNP Paribas Financial Markets SNC | Position 15,948,104 shares | Ratio 0.85% | ▼0.10% | — |
| 2026-09-15 | J.P. MORGAN SECURITIES PLC | Position 22,670,333 shares | Ratio 1.21% | ▼0.20% | — |
| 2026-09-15 | BNP Paribas Financial Markets SNC | Position 17,711,360 shares | Ratio 0.95% | ▲0.54% | — |
| 2026-09-11 | J.P. MORGAN SECURITIES PLC | Position 26,376,623 shares | Ratio 1.41% | ▲0.73% | — |
| 2026-09-10 | J.P. MORGAN SECURITIES PLC | Position 12,785,168 shares | Ratio 0.68% | ▼0.14% | — |
| 2026-09-03 | J.P. MORGAN SECURITIES PLC | Position 15,426,518 shares | Ratio 0.82% | ▲0.82% | — |
| 2026-04-08 | J.P. MORGAN SECURITIES PLC | Position 0 shares | Ratio 0.00% | ▼0.53% | Closed |
| 2026-04-07 | J.P. MORGAN SECURITIES PLC | Position 10,072,234 shares | Ratio 0.53% | ▲0.12% | — |
Shorted Stocks in the Same Industry Pharmaceutical
| Stock | Estimated ratio | Short sellers |
|---|---|---|
| GNI Group Ltd.2160 | 11.16% | 7 firms |
| Oncolys BioPharma Inc.4588 | 10.35% | 7 firms |
| HEALIOS K.K.4593 | 10.20% | 5 firms |
| SymBio Pharmaceuticals Limited4582 | 9.46% | 7 firms |
| Nxera Pharma Co.,Ltd.4565 | 7.35% | 5 firms |
Related Stocks Same TSE 33 sector
| Stock | Market | TSE 33 Sector | TOPIX-17 Sector | Index |
|---|---|---|---|---|
| CHUKYO IYAKUHIN CO.,LTD.4558 | Standard Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| ZERIA PHARMACEUTICAL CO.,LTD.4559 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Small 1 |
| AnGes,Inc.4563 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| OncoTherapy Science,Inc.4564 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Nxera Pharma Co.,Ltd.4565 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Small 1 |
| KYORIN Pharmaceutical Co.,Ltd.4569 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Small 1 |
| Immuno-Biological Laboratories Co.,Ltd.4570 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Nano Holdings,Inc.4571 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Carna Biosciences,Inc.4572 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| TAIKO PHARMACEUTICAL CO.,LTD.4574 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Small 2 |